Yellowstone Advisory Private Investor Evening

Fevara

30/04/2026 07:00

RNS Number : 4655C

Fevara PLC

30 April 2026

 

30 April 2026

Fevara plc

("Fevara", the "Company" or the "Group")

Presentation and Q&A at Yellowstone Advisory Private Investor Evening

Fevara plc (LSE: FVA), an international specialist in livestock supplements, is pleased to announce that Josh Hoopes, Chief Executive Officer and Gavin Manson, Chief Financial Officer will be attending and presenting at the Yellowstone Advisory Private Investor evening on 13 May.

The event is being held at the offices of Hudson Sandler in London (25 Charterhouse Square, EC1M 6AE) and investors can register for the event here. 

If you have any questions about the evening please email info@yellowstoneadvisory.com

- Ends -

For further information, please contact:

Enquiries

Fevara plc
+44 (0) 1228 554 600
Joshua Hoopes, Chief Executive Officer
Gavin Manson, Chief Financial Officer
Hudson Sandler
+44 (0)Â 20 7796 4133
Hattie Dreyfus / Nick Moore / Francesca Rosser


 

About Fevara plc:

Fevara is an international specialist in livestock supplements.

 

Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture.  The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including CrystalyxŽ, HorslicŽ, HorslyxŽ, Scotmin NutritionŽ, SmartLicŽ, TracesureŽ Advanced and MacalŽ.

 

Headquartered in Carlisle, Cumbria, in the UK, Fevara has six manufacturing sites in the UK, US and Brazil with two operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.

 

Fevara has been listed on the London Stock Exchange since 1972.

 

For more information, visit: www.fevara.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NRAQKLFLQZLBBBD